Volume : 11, Issue : 08, August – 2024

Title:

DEVELOPMENT AND EVALUATION OF AN OSMOTIC DRUG DELIVERY SYSTEM FOR GLIBENCLAMIDE USING QUALITY ASSESSMENT METHODS

Authors :

Kanchan S. Jamkar*, Shankar Musale, Vidya D. Waghmode, Jayashree B. Shinde, Sachin H. Lanjewar, Yash. S. Acharya, Harshada S. Sonavdekar, Shubhada V. Bhopale

Abstract :

Recent advancements in Novel Drug Delivery Systems (NDDS) have significantly impacted the pharmaceutical industry by enhancing the effectiveness of existing drug molecules. Oral Osmotic Pumps, a key innovation, offer controlled and prolonged drug release, which overcomes the limitations of conventional drug delivery systems that often lack precision in drug release, leading to unpredictable plasma levels. Unlike traditional systems, osmotic drug delivery is independent of physiological factors like gastric pH, making it more reliable. These systems utilize osmosis to control drug release, with innovations such as Hydrodynamic Pressure Controlled Systems and Intragastric Floating Tablets further improving therapeutic outcomes. This research focuses on the development of an osmotic drug delivery system for Glibenclamide, an antidiabetic medication. Glibenclamide, a BCS Class II drug with a short elimination half-life, requires frequent dosing, which can lead to noncompliance. The proposed controlled porosity osmotic pump aims to enhance patient compliance, improve efficacy, and provide consistent bioavailability by utilizing osmotic agents and polymers like HPMC K100M to control drug release. Advanced Quality Assessment Techniques such as Design of Experiments (DoE) and Quality by Design (QbD) were employed to optimize the formulation, ensuring reliable and effective treatment for patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM).
Keywords: NDDS, Controlled porosity Osmotic System, Glibenclamide, Quality assessment methods

Cite This Article:

Please cite this article in press Kanchan S. Jamkar et al., Development And Evaluation Of An Osmotic Drug Delivery System For Glibenclamide Using Quality Assessment Methods., Indo Am. J. P. Sci, 2024; 11 (08).

Number of Downloads : 10

References:

1. Sancheti V, Chordiya M, Senthilkumaran K. A review on osmotically controlled drug delivery systems. World J Pharma. 2003;3(12):1708-1728.
2. Srikanth P, Narayana R, Wasim S, Brito R. A review on oral controlled drug delivery systems. Int J Advanced Pharma. 2013;1(3):51-58.
3. Nikam PH, Kareparambanj A, Jadhav AP, Kadam VJ. Osmotic pump: A reliable drug delivery system. Res J Pharma Bio Chem Sci. 2012;3(3):478.
4. Mane SS, Kamble SM, Chaudhari P, Bhosle A. Review article: An overview on oral osmotically controlled drug delivery systems. Int J Universal Sci Life Sci. 2012;2(2).
5. Singh MS, Pancholi SS. Comparative studies on dissolution enhancement of glibenclamide in solid dispersions made by different techniques. Int J Pharmaceutical Erudition. 2012;1(4):33-42.
6. Dhillon B, Goyal NK, Sharma PK. Formulation and evaluation of glibenclamide solid dispersion using different methods. Global J Pharmacology. 2014;8(4):551-556.
7. Gianotto EA, Saraiva AC. Dissolution test for glibenclamide tablets. Quim Nova. 2007;30(5):1218-1221.
8. EapenC ,Prasanth V and Rai A. Development of UV Spectrometric Method of Glibenclamide (Glyburide) in Bulk and Pharmaceutical Formulations, Int. J. of Chem Tech Res. 2012; 4(1): 356-360.
9. Camelia N, Cornia A. Phase solubility studies of the inclusion complex of repaglinide with b-cyclodextrin and b-cyclodextrin derivative. 2010; 58(5):620-628
10. Majahar SK, Rao RM. Studies on the preparation characterization and solubility of Nimodipine inclusion complexes with b-cyclodextrin. Int J Pharma biosciences. 2010; 1(2):1-8
11. Srikanth MV, Murali GV. Dissolution rate enhancement of poorly soluble bicalutamide using ß-cyclodetxrin inclusion complexation. Int J Pharm Pharma Sci. 2010; 2(1); 191-198
12. Chandrakant DS, Lingaray SD. Preparation and evaluation of inclusion Complexes of water soluble drugs. Int J Res Pharm Biomedical Sci. 2011; 2(4):1599-1616
13. Imran S, Vishal G. Preparation and characterization of b-cyclodextrin aspirin inclusion complex. Int J Pharm Life science. 2011; 2(4):704-710
14. HimansuBhusan S, Jitendra D. Solubility and dissolution improvement of Aceclofenac using b-cyclodextrin. Int J Drug Dev Res. 2012; 4(4):326-333
15. Sreenivasa R, Mohammed M. Preparation and evaluation of cyclodextrin inclusion complex of water insoluble drug-glimepiride. Int J Res In Pharma biomedical Sci. 2012; 3(1):428-434
16. Vivekanand C, Abhishek M. Zaltoprofen B-CD inclusion complex for solubility enhancement. J Pharm Sci Tech. 2013; 3(1): 37-42.
17. .The Indian Pharmacopoeia. The Controller of Publication. 2007; 1: 182- 183.
18. Lachman L, Lieberman H. The Theory and Practice of Industrial Pharmacy. 1991; (3): 67-71, 183- 184.
19. Martindale W, Reynolds J. Martindale. The Extra Pharmacopoeia. The Pharmaceutical Press, London. 1996:31: 936–937.
20. Himansu Bhusan S, Jitendra D. Solubility and dissolution improvement of aceclofenac using β-cyclodextrin. Int J Drug Dev Res. 2012;4(4):326-333.
21. Sreenivasa R, Mohammed M. Preparation and evaluation of cyclodextrin inclusion complex of water-insoluble drug glimepiride. Int J Res Pharma Biomed Sci. 2012;3(1):428-434.
22. Vivekanand C, Abhishek M. Zaltoprofen β-CD inclusion complex for solubility enhancement. J Pharm Sci Tech. 2013;3(1):37-42.
23. The Indian Pharmacopoeia. The Controller of Publications. 2007;1:182-183.
24. Lachman L, Lieberman H. The Theory and Practice of Industrial Pharmacy. 1991; 3:67-71, 183-184.
25. Martindale W, Reynolds J. Martindale: The Extra Pharmacopoeia. The Pharmaceutical Press, London. 1996;31:936-937.
26. Bahri-N, Tavakoli N, Senemar M, Peikanpour M. Preparation and pharmaceutical evaluation of glibenclamide slow release buccal film. 2013.
27. Sharkheliya DB, Sharma R, Rajawat SG. Formulation development and assessment of controlled release bilayered osmotic tablet carrying sulfonylurea class – anti-diabetic agent & imperative factors imparting significant impact on drug release. Int J Res Pharm Sci. 2013; 3(2):102-122.
28. Sastri P, Ravikumar, Kalra A, Kanagale A. Enhancement of dissolution of glipizide from controlled porosity osmotic pump using a wicking agent and a solubilizing agent. Int J Pharm Tech Res. 2009;1(3):705-711.
29. Bharadwaj P, Upadhyay PK, Agarwal V, Chaurasia D, Chaurasia H, Singh R. Development and characterization of elementary osmotic pump tablets for simultaneous release of metformin and glipizide. Indian Drugs. 2012;49(11).
30. Mahalaxmi R. Enhancement of dissolution of glipizide from controlled porosity osmotic pump using a wicking agent and a solubilizing agent. Int J Pharm Tech Res. 2009;1(3):705-711.
31. Vyas SP, et al. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: Development and in-vitro characterization. Int J Pharm. 2004;284:95-108.
32. Mina Rani, et al. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium. Acta Pharm. 2003;53:263-273.
33. Jayaprakash S, Halith S. Formulation and evaluation of bilayer tablets of amlodipine besilate and metoprolol succinate. Der Pharmacia Lettre. 2011;3(4):143-154.
34. Mishra R. Plasticizer effect and comparative evaluation of cellulose acetate and ethyl cellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium. Drug Dev Ind Pharm. 2002;28(4):403-412.
35. Brahmankar D. Biopharmaceutics and Pharmacokinetics- A Treaties. 2009; 2: 430-450.
36. Kuchekar B, Singavi A, et al. Indian Drugs. 2003; 40(1): 44-45.
37. Brahmankar D. Biopharmaceutics and Pharmacokinetics- A Treaties. 2009; 2: 430-450.
38. Vidya D. Waghmode, Akash S. Malthankar, Supriya S. Darandale, Rajiya A. Khan, Swati D. Bankar, Priyanka S. Ingale, Vishal R. Rasve, Formulation And Evaluation Of An Osmotic Drug Delivery System For An Antidiabetic Drug , Int. J. of Pharm. Sci., 2024, Vol 2, Issue 8, 2575-2592. https://doi.org/10.5281/zenodo.13219968.
39. Kulkarni A, Shahvavaz M. Development and Validation of a Dissolution Method for Pioglitazone. Dissolution Technologies; 2012: 36-45.
40. Mohiuddin M.Z, Puligilla s, Chukka S, Devadasu V, PentaJ.Research Article Formulation and Evaluation of Glyburide Liquisolid Compacts, IJPRR.2014; 3(2) 36-46.
41. Avula PR, VeesamH.Influence of dependent variables on granule formulation using factorial design: microwave irradiation as one of the factor. Int J Pharm Res. 2013; 2(7): 115-118.
42. Khan MA. Formulation of Sustained Release Diltiazem Hydrochloride Matrix Tablets through Optimization and Their Evaluation. J Pharm Bio Chem Res. 2013; 4(2): 1317-1325.
43. Alexander M, Saini G. Factorial design used in optimization immediate release solid dosage Ranitidine HCl. Estud Biol. 2006; 28(62): 17-25.
44. Sharma S, Singh G. Formulation design and optimization of mouth designing tablets of Domperidone using sublimation technique. Int J Pharm Sci. 2010; 1(1): 128-135.
45. Sudha T. , Vamsi K., V.R. Ravi Kumar, Development and Validation of an Analytical Method for Glyburide and Its Related Compounds in Tablet Formulation by HPLC-UV. Turk J Pharm Sci 2014; 11(3):307-316.
46. Kulkarni A, Shahvavaz M. Development and Validation of a Dissolution Method for Pioglitazone. Dissolution Technologies; 2012: 36-45.
47. .Remington. Lippincot Williams and Wilkins. The Science and Practice of Pharmacy. 2007;(20): 907-910, 929-938, 945-950.